DWA
PRPH

Dorsey Wright & Associates’s ProPhase Labs PRPH Stock Holding History

Dorsey Wright & Associates’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-207
Closed -$20K – 350
2022
Q4 		$20K Buy
+207
New +$22.4K 0.01% 266
2021
Q1 		– Sell
-136
Closed -$12K – 356
2020
Q4 		$12K Buy
+136
New +$11.4K ﹤0.01% 288

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dorsey Wright & Associates's PRPH Position: Q1 2023 in Review

Dorsey Wright & Associates sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 207 shares — an estimated $20K sold.

Dorsey Wright & Associates first reported a position in PRPH in Q4 2020 and held it in 2 quarters. The position peaked at $20K in Q4 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.

  • Dorsey Wright & Associates reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 207 ProPhase Labs shares in Q1 2023, an estimated $20K.
  • Dorsey Wright & Associates first reported a position in ProPhase Labs in Q4 2020 and held it in 2 quarters.
  • Dorsey Wright & Associates's ProPhase Labs position peaked at $20K in Q4 2022.
  • 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.

Based on Dorsey Wright & Associates's 13F filing for Q1 2023, filed 20 Apr 2023.